Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  teniposide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 162 for your search:
Start Over
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
Phase II/III Randomized Comparison of Up-Front Alternating Chemotherapy vs Up-Front Intensive 6-MP/MTX for Poor Prognosis Childhood ALL
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
Phase III Study with CACP vs ADR/CTX/CACP & Phase II Study with VM-26 for Disseminated Transitional Cell Urinary Tract Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: EST-1878
Phase III Comparison of IPP/AMSA/VP-16 vs IPP/AMSA/VM-26 in Patients with Relapsed Hodgkin's and non-Hodgkin's Lymphomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-043-156, MDA-DT-8071
Postoperative Radiotherapy and Combination Chemotherapy with BCNU, PCB, HU, and VM-26 for Malignant Glioma
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor:
Protocol IDs: BTSG-8001
Phase III Chemotherapy with Sequential CTX/ADR with/without VM-26 and CPDD plus Cyclic VCR/CTX/DTIC for Childhood Metastatic Neuroblastoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 16
Sponsor: NCI
Protocol IDs: CCG-371
Phase III Surgery, Radiotherapy, and Chemotherapy with ADR, CACP, CTX, and VM-26 for Localized and Disseminated Neuroblastoma: An Age-Oriented Study
Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8104/05
Phase III Pilot Study with CTX/VCR/DTIC Followed by CTX/ADR Alternating with VM-26 for Stage III and IV Childhood Neuroblastoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 16
Sponsor: NCI
Protocol IDs: CCG-371P/373P
Phase III Combination Chemotherapy for Treatment of Childhood ALL and AUL After Relapse or Induction Failure
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: CCG-121
Phase III Surgery plus Chemotherapy with CTX/ADR and CACP/VM-26 with or without Radiotherapy for Stage I/II/III Neuroblastoma and Ganglioneuroblastoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor:
Protocol IDs: NCI-D81-050-885, SJCRH-NB-79-B
Phase III Maintenance Chemotherapy with VM-26/ARA-C Alternating with MTX/L-ASP Following Reinduction in Relapsed ALL and NHL
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: NCI-D82-006-762, YALE-HIC-2571
Phase III Induction (VCR/PRED/DNM), Consolidation (ARA-C/L-ASP plus CTX/DNM/VCR/PRED), and Maintenance (6-MP/MTX) for Adult ALL, with Salvage Therapy (VM-26/ARA-C) for Failures
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: UCCRC-3583, ICC-82L3, NCI-D82-014-968
Phase III Combination Chemotherapy for Childhood Acute Lymphocytic Leukemia in Patients at Standard Risk
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-TOT-10S, NCI-D81-050-884
Phase III PVDA Reinduction plus VM-26/ARA-C Consolidation plus Continuation with/without Reinforcement for Childhood ALL in First Relapse
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: COG-8303, POG-8303
Start Over